Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP213170.RACcOf4GAHFC4z5kq0G8PSvYHHiB8Pl3GmhLdH6qEEQtE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP213170.RACcOf4GAHFC4z5kq0G8PSvYHHiB8Pl3GmhLdH6qEEQtE130_assertion type Assertion NP213170.RACcOf4GAHFC4z5kq0G8PSvYHHiB8Pl3GmhLdH6qEEQtE130_head.
- NP213170.RACcOf4GAHFC4z5kq0G8PSvYHHiB8Pl3GmhLdH6qEEQtE130_assertion description "[Phosphorylation of ER-alpha Ser167 is helpful in selecting patients who may benefit from endocrine therapy and is a prognostic marker in metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP213170.RACcOf4GAHFC4z5kq0G8PSvYHHiB8Pl3GmhLdH6qEEQtE130_provenance.
- NP213170.RACcOf4GAHFC4z5kq0G8PSvYHHiB8Pl3GmhLdH6qEEQtE130_assertion evidence source_evidence_literature NP213170.RACcOf4GAHFC4z5kq0G8PSvYHHiB8Pl3GmhLdH6qEEQtE130_provenance.
- NP213170.RACcOf4GAHFC4z5kq0G8PSvYHHiB8Pl3GmhLdH6qEEQtE130_assertion SIO_000772 16168121 NP213170.RACcOf4GAHFC4z5kq0G8PSvYHHiB8Pl3GmhLdH6qEEQtE130_provenance.
- NP213170.RACcOf4GAHFC4z5kq0G8PSvYHHiB8Pl3GmhLdH6qEEQtE130_assertion wasDerivedFrom lhgdn-20090331 NP213170.RACcOf4GAHFC4z5kq0G8PSvYHHiB8Pl3GmhLdH6qEEQtE130_provenance.
- NP213170.RACcOf4GAHFC4z5kq0G8PSvYHHiB8Pl3GmhLdH6qEEQtE130_assertion wasGeneratedBy ECO_0000203 NP213170.RACcOf4GAHFC4z5kq0G8PSvYHHiB8Pl3GmhLdH6qEEQtE130_provenance.